Contact Us

Zometa
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Zometa

Study Finds Bisphosphonate Fracture Risk Increases with Longer Use

May 22, 2012
| Parker Waichman LLP
For the second time in a week, a new study is raising serious concerns about long-term use of Fosamax and other bisphosphonates.  The study,...

Bisphosphonates May be Less Effective in Preventing Fractures after Five Years

May 10, 2012
| Parker Waichman LLP
A new study published in the New England Journal of Medicine is raising new concerns about the efficacy of long-term bisphosphonate therapy. ...

Health Canada Revises Bisphosphonate Labels with Fracture Warning

Dec 20, 2011
| Parker Waichman LLP
Health Canada has announced that its review of bisphosphonates has shown a slightly increased risk of atypical thigh fractures among people who use...

Bisphoshonate Benefits Plateau at Five Years, FDA Says

Sep 8, 2011
| Parker Waichman LLP
Women who take oral bisphosphonates such as Fosamax to prevent broken bones from osteoporosis may not have to take them beyond five years to get...

Increased Vitamin D Might Make Bisphosphonates More Effective

Jun 9, 2011
| Parker Waichman LLP
Vitamin D supplementation might help bisphosphonates like Fosamax do a better job of protecting bones, a new study says.  The study, conducted...

Bisphosphonate Study Finds Link to Rare Thigh Fractures

May 5, 2011
| Parker Waichman LLP
Another study, this time out of Sweden, has found a link between bisphosphonates, such as Fosamax, and a rare type of thigh fracture in women....

Zometa, Reclast, Boniva Infusions Linked to Eye Inflammation

Sep 26, 2008
| Parker Waichman LLP
Zometa, Reclast and Boniva infusions have been linked to a rare inflammatory eye disease, according to a letter published in the "New England...

BONE-DENSITY DRUGS CAN KILL JAWS

Jul 5, 2006
| Philadelphia Inquirer
Across the country, dentists have begun asking patients a pointed question before deciding on treatment: Do you take a bone-building medication such...

Another Merck Drug Is Under Legal Attack

Jul 5, 2006
| Los Angeles Times
As Merck & Co. defends itself against a deluge of litigation involving its pain reliever Vioxx, the pharmaceutical giant also is fielding the...

Jaw Complications May Be Linked to Bone-Saving Drugs

Jun 22, 2005
| www.rednova.com
Three months after Betty Beckman had a broken tooth pulled, her jaw still hasn't healed.So the Nebraska City woman travels each weekday to Omaha,...

Page 1/2 [first] [prev] 1 2 [next] [last]